Iradimed (IRMD) Receivables (2013 - 2026)

Iradimed (IRMD) has 14 years of Receivables data on file, last reported at $13.4 million in Q1 2026.

• Receivables for Q1 2026 came in at $13.4 million, up 5.58% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.4 million (up 5.58% YoY), and the FY2025 annual result was $13.7 million, up 29.47% from the prior year.
• Receivables fell to $13.4 million in Q1 2026 per IRMD's latest filing, from $13.7 million in the prior quarter.
• Over five years, Receivables peaked at $13.9 million in Q3 2025 and troughed at $6.5 million in Q1 2022.
• A 5-year average of $11.6 million and a median of $12.0 million in 2024 frame the typical range for Receivables.
• The sharpest annual moves came in 2022 and 2024: Receivables soared 158.43% in 2022, then slipped 18.92% in 2024.
• A 5-year view of Receivables shows it stood at $13.3 million in 2022, then decreased by 7.91% to $12.2 million in 2023, then declined by 13.65% to $10.6 million in 2024, then advanced by 29.47% to $13.7 million in 2025, then slipped by 1.84% to $13.4 million in 2026.
• Business Quant data shows IRMD's Receivables at $13.4 million in Q1 2026, $13.7 million in Q4 2025, and $13.9 million in Q3 2025.